BIONDINI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 3.247
AS - Asia 1.150
EU - Europa 1.101
SA - Sud America 313
AF - Africa 279
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.132
Nazione #
US - Stati Uniti d'America 3.112
IT - Italia 390
SG - Singapore 361
CN - Cina 259
BR - Brasile 232
HK - Hong Kong 148
DE - Germania 86
SE - Svezia 75
FI - Finlandia 74
VN - Vietnam 61
PL - Polonia 47
FR - Francia 46
RU - Federazione Russa 41
GB - Regno Unito 36
IN - India 34
NL - Olanda 31
TR - Turchia 29
KR - Corea 28
IE - Irlanda 25
AT - Austria 20
CI - Costa d'Avorio 19
ES - Italia 19
ZA - Sudafrica 19
AR - Argentina 18
MX - Messico 17
BD - Bangladesh 15
LB - Libano 15
CA - Canada 14
AU - Australia 13
BE - Belgio 13
BY - Bielorussia 13
CZ - Repubblica Ceca 13
EC - Ecuador 12
ID - Indonesia 12
JP - Giappone 12
PT - Portogallo 12
SN - Senegal 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
AO - Angola 11
AZ - Azerbaigian 11
BB - Barbados 11
CD - Congo 11
CH - Svizzera 11
GE - Georgia 11
MD - Moldavia 11
TJ - Tagikistan 11
CR - Costa Rica 10
HR - Croazia 10
HU - Ungheria 10
ME - Montenegro 10
BF - Burkina Faso 9
BG - Bulgaria 9
CO - Colombia 9
GM - Gambi 9
JO - Giordania 9
KH - Cambogia 9
LU - Lussemburgo 9
LY - Libia 9
MU - Mauritius 9
MZ - Mozambico 9
RS - Serbia 9
SA - Arabia Saudita 9
TN - Tunisia 9
UA - Ucraina 9
UZ - Uzbekistan 9
BS - Bahamas 8
ET - Etiopia 8
KE - Kenya 8
MA - Marocco 8
MW - Malawi 8
NO - Norvegia 8
PH - Filippine 8
VE - Venezuela 8
BO - Bolivia 7
BZ - Belize 7
DK - Danimarca 7
GT - Guatemala 7
IQ - Iraq 7
IR - Iran 7
LV - Lettonia 7
NC - Nuova Caledonia 7
PR - Porto Rico 7
PY - Paraguay 7
RE - Reunion 7
SO - Somalia 7
TH - Thailandia 7
TZ - Tanzania 7
YT - Mayotte 7
ZM - Zambia 7
AM - Armenia 6
BW - Botswana 6
CL - Cile 6
CU - Cuba 6
CV - Capo Verde 6
EG - Egitto 6
GF - Guiana Francese 6
GH - Ghana 6
IS - Islanda 6
KG - Kirghizistan 6
Totale 5.904
Città #
Fairfield 510
Ashburn 409
Woodbridge 273
Singapore 236
Chandler 222
Houston 185
Seattle 176
Cambridge 169
Hong Kong 144
Wilmington 128
Ann Arbor 103
Beijing 90
Santa Clara 70
Los Angeles 57
Boardman 53
Munich 48
Padova 43
Helsinki 41
San Diego 41
Bytom 37
Medford 35
Princeton 33
Roxbury 28
Hefei 27
Des Moines 24
New York 24
Dallas 23
Dublin 22
Ho Chi Minh City 22
Trieste 20
Turku 20
Seoul 19
São Paulo 19
Pune 16
Abidjan 15
Buffalo 14
Dong Ket 14
Jinan 14
Pordenone 14
Council Bluffs 12
Dakar 12
Ogden 12
Bridgetown 11
Dushanbe 11
Johannesburg 11
Rio de Janeiro 11
Vienna 11
Baku 10
Chicago 10
London 10
Luanda 10
Milan 10
Nanjing 10
Amman 9
Podgorica 9
Udine 9
Azzano Decimo 8
Città Sant'Angelo 8
Kinshasa 8
Minsk 8
Stockholm 8
Tokyo 8
Washington 8
Zagreb 8
Lusaka 7
Luxembourg 7
Melbourne 7
Nairobi 7
Nassau 7
Noumea 7
Phnom Penh 7
Tashkent 7
Tbilisi 7
Villafranca Padovana 7
Ankara 6
Annone Veneto 6
Banjul 6
Bishkek 6
Brussels 6
Cagliari 6
Castries 6
Dar es Salaam 6
Fossò 6
Gaborone 6
Hanoi 6
Havana 6
Kampala 6
Managua 6
Nuremberg 6
Ouagadougou 6
Praia 6
Reykjavik 6
San José 6
Tripoli 6
Ulan Bator 6
Accra 5
Atlanta 5
Brooklyn 5
Budapest 5
Chisinau 5
Totale 3.901
Nome #
From cigarette smoking to Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis. Why? 295
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 218
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 215
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 200
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 189
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 187
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 179
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 174
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 169
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 169
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 157
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 144
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 143
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 142
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 139
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 137
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 135
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 134
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies 133
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 132
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 131
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients 131
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 129
Risk Factors for Development and Severity of COVID-19 in COPD Patients 126
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 124
Successful lung retransplantation in a patient with acute fibrinous and organizing pneumonia: A case report 123
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 122
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 122
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 120
Idiopathic pulmonary fibrosis and lung transplantation: When it is feasible 115
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment 109
Exome sequencing in diseased and healthy subjects with alpha-1 antitrypsin deficiency 102
Editorial: New insights in sarcoidosis: from bench to bedside 101
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 100
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment 99
Herpes simplex virus 2 hepatitis in a lung transplant recipient: A diagnostic challenge 92
Pulmonary fibrosis secondary to COVID-19: a call to arms? 90
The role of bronchoscopy in the diagnosis and management of patients with sars-cov-2 infection 88
Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters? 87
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey 84
Symptomatic smokers without COPD have physiological changes heralding the development of COPD 82
Endobronchial solitary fibrous tumors: An enigma for diagnosis 81
Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD? 75
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison? 71
Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities 71
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 66
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences 61
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease 58
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF) 49
Unveiling the Cutting-Edge Impact of Polarized Macrophage-Derived Extracellular Vesicles and MiRNA Signatures on TGF-β Regulation within Lung Fibroblasts 43
What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review 11
Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience 7
Totale 6.261
Categoria #
all - tutte 22.949
article - articoli 20.764
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021586 0 0 0 45 26 28 93 46 88 124 89 47
2021/2022635 23 26 112 46 68 34 18 90 76 11 27 104
2022/2023489 84 33 23 48 84 49 10 42 76 7 27 6
2023/2024461 10 52 49 29 40 86 26 37 22 35 38 37
2024/20251.509 49 115 90 65 137 64 96 115 128 68 262 320
2025/20261.521 329 448 733 11 0 0 0 0 0 0 0 0
Totale 6.261